• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

骨碎补总黄酮通过抑制NF-和PI3K/AKT通路的激活来恢复骨关节炎模型中的MMP/TIMP平衡。

Total Flavonoids of Rhizoma Drynariae Restore the MMP/TIMP Balance in Models of Osteoarthritis by Inhibiting the Activation of the NF- and PI3K/AKT Pathways.

作者信息

Chen Guang-Yao, Chen Jia-Qi, Liu Xiao-Yu, Xu Yuan, Luo Jing, Wang Yi-Fei, Zhou Tong-Liang, Yan Ze-Ran, Zhou Li, Tao Qing-Wen

机构信息

Beijing University of Chinese Medicine, Beijing 100029, China.

Department of TCM Rheumatology, China-Japan Friendship Hospital, Beijing 100029, China.

出版信息

Evid Based Complement Alternat Med. 2021 Apr 19;2021:6634837. doi: 10.1155/2021/6634837. eCollection 2021.

DOI:10.1155/2021/6634837
PMID:33995548
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8081598/
Abstract

Total flavonoids of (TFRD) have been shown to have beneficial effects on osteoarthritis (OA) clinically, but the mechanisms have not been elucidated. In this study, we investigated the effect of TFRD on articular cartilage in an OA rat model established by the Hulth method and in SW1353 chondrocytes induced by the proinflammatory factor interleukin-1 (IL-1). The results showed that TFRD could alleviate the pathological changes in knee cartilage in OA model rats. In vivo, the qPCR analysis indicated that the mRNA levels of matrix metalloproteinases, MMP-1, MMP-3, and MMP-13, were decreased, while tissue inhibitor of matrix metalloproteinases- (TIMP-) 4 was increased in cartilage, and these changes could be partially prevented by TFRD. In vitro experiments showed that IL-1 could significantly increase the expression of MMP-1, MMP-3, and MMP-13 and decrease the expression of TIMP-4 in SW1353 cells at the mRNA and protein levels. TFRD could increase the expression of MMP-3 and MMP-13 and decrease the expression of TIMP-4. Transfection of siRNA and addition of pathway inhibitors were used to clarify that inhibition of NF- and PI3K/AKT pathway decreased MMP-1, MMP-3, and MMP-13 and increased TIMP-4 expression. We also found that in IL-1-induced SW1353 cells, TFRD pretreatment had a modest inhibitory effect on p-AKT (Ser473) and reversed the increase of nuclear factor kappa-B (NF-) p65 in nuclear fraction and the decrease of inhibitor of NF-()- in the cytosolic fraction. Further immunofluorescence confirmed that TFRD can inhibit IL-1-induced NF- p65 translocation to the nucleus to some extent. In conclusion, TFRD showed chondroprotective effects by restoring the MMP/TIMP balance in OA models by suppressing the activation of the NF- and PI3K/AKT pathways.

摘要

(某物质)总黄酮(TFRD)在临床上已显示出对骨关节炎(OA)具有有益作用,但其机制尚未阐明。在本研究中,我们研究了TFRD对通过Hulth方法建立的OA大鼠模型以及由促炎因子白细胞介素-1(IL-1)诱导的SW1353软骨细胞中关节软骨的影响。结果表明,TFRD可减轻OA模型大鼠膝关节软骨的病理变化。在体内,qPCR分析表明,软骨中基质金属蛋白酶MMP-1、MMP-3和MMP-13的mRNA水平降低,而基质金属蛋白酶组织抑制剂-(TIMP-)4增加,并且这些变化可被TFRD部分阻止。体外实验表明,IL-1可在mRNA和蛋白质水平上显著增加SW1353细胞中MMP-1、MMP-3和MMP-13的表达,并降低TIMP-4的表达。TFRD可增加MMP-3和MMP-13的表达,并降低TIMP-4的表达。使用siRNA转染和添加通路抑制剂来阐明抑制NF-和PI3K/AKT通路可降低MMP-1、MMP-3和MMP-13并增加TIMP-4的表达。我们还发现,在IL-1诱导的SW1353细胞中,TFRD预处理对p-AKT(Ser473)有适度的抑制作用,并逆转了核部分中核因子κB(NF-)p65的增加以及胞质部分中NF-()抑制剂的减少。进一步的免疫荧光证实,TFRD可在一定程度上抑制IL-1诱导的NF- p65向细胞核的转位。总之,TFRD通过抑制NF-和PI3K/AKT通路的激活来恢复OA模型中的MMP/TIMP平衡,从而显示出软骨保护作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc93/8081598/f22ed775dc6f/ECAM2021-6634837.014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc93/8081598/34cb26b5046e/ECAM2021-6634837.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc93/8081598/ca914a99e2c1/ECAM2021-6634837.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc93/8081598/b6c405b109fe/ECAM2021-6634837.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc93/8081598/630b10fb14fc/ECAM2021-6634837.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc93/8081598/48d465ca5876/ECAM2021-6634837.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc93/8081598/f1d37cf192b7/ECAM2021-6634837.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc93/8081598/f70d840aecbb/ECAM2021-6634837.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc93/8081598/968f1675ab55/ECAM2021-6634837.008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc93/8081598/50995fe79f7b/ECAM2021-6634837.009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc93/8081598/a09082fd9696/ECAM2021-6634837.010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc93/8081598/227aceb83168/ECAM2021-6634837.011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc93/8081598/0d7a9b79f2d2/ECAM2021-6634837.012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc93/8081598/682c2a7414ff/ECAM2021-6634837.013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc93/8081598/f22ed775dc6f/ECAM2021-6634837.014.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc93/8081598/34cb26b5046e/ECAM2021-6634837.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc93/8081598/ca914a99e2c1/ECAM2021-6634837.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc93/8081598/b6c405b109fe/ECAM2021-6634837.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc93/8081598/630b10fb14fc/ECAM2021-6634837.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc93/8081598/48d465ca5876/ECAM2021-6634837.005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc93/8081598/f1d37cf192b7/ECAM2021-6634837.006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc93/8081598/f70d840aecbb/ECAM2021-6634837.007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc93/8081598/968f1675ab55/ECAM2021-6634837.008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc93/8081598/50995fe79f7b/ECAM2021-6634837.009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc93/8081598/a09082fd9696/ECAM2021-6634837.010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc93/8081598/227aceb83168/ECAM2021-6634837.011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc93/8081598/0d7a9b79f2d2/ECAM2021-6634837.012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc93/8081598/682c2a7414ff/ECAM2021-6634837.013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bc93/8081598/f22ed775dc6f/ECAM2021-6634837.014.jpg

相似文献

1
Total Flavonoids of Rhizoma Drynariae Restore the MMP/TIMP Balance in Models of Osteoarthritis by Inhibiting the Activation of the NF- and PI3K/AKT Pathways.骨碎补总黄酮通过抑制NF-和PI3K/AKT通路的激活来恢复骨关节炎模型中的MMP/TIMP平衡。
Evid Based Complement Alternat Med. 2021 Apr 19;2021:6634837. doi: 10.1155/2021/6634837. eCollection 2021.
2
Total Flavonoids of Rhizoma Drynariae Treat Osteoarthritis by Inhibiting Arachidonic Acid Metabolites Through AMPK/NFκB Pathway.骨碎补总黄酮通过AMPK/NFκB途径抑制花生四烯酸代谢产物治疗骨关节炎
J Inflamm Res. 2023 Sep 20;16:4123-4140. doi: 10.2147/JIR.S418345. eCollection 2023.
3
Mori folium inhibits interleukin-1β-induced expression of matrix metalloproteinases and inflammatory mediators by suppressing the activation of NF-κB and p38 MAPK in SW1353 human chondrocytes.桑白皮通过抑制 NF-κB 和 p38 MAPK 的激活抑制白细胞介素-1β诱导的 SW1353 人软骨细胞基质金属蛋白酶和炎症介质的表达。
Int J Mol Med. 2016 Feb;37(2):452-60. doi: 10.3892/ijmm.2015.2443. Epub 2015 Dec 23.
4
Shikonin inhibits inflammatory responses in rabbit chondrocytes and shows chondroprotection in osteoarthritic rabbit knee.紫草素抑制兔软骨细胞的炎症反应,并在骨关节炎兔膝关节中显示软骨保护作用。
Int Immunopharmacol. 2015 Dec;29(2):656-662. doi: 10.1016/j.intimp.2015.09.014. Epub 2015 Sep 26.
5
Vorinostat, a HDAC inhibitor, showed anti-osteoarthritic activities through inhibition of iNOS and MMP expression, p38 and ERK phosphorylation and blocking NF-κB nuclear translocation.伏立诺他,一种组蛋白去乙酰化酶抑制剂,通过抑制 iNOS 和 MMP 的表达、p38 和 ERK 的磷酸化以及阻断 NF-κB 核易位,显示出抗骨关节炎活性。
Int Immunopharmacol. 2013 Oct;17(2):329-35. doi: 10.1016/j.intimp.2013.06.027. Epub 2013 Jul 13.
6
Prediction of Rhizoma Drynariae Targets in the Treatment of Osteoarthritis Based on Network Pharmacology and Experimental Verification.基于网络药理学和实验验证预测骨碎补治疗骨关节炎的靶点
Evid Based Complement Alternat Med. 2021 Nov 18;2021:5233462. doi: 10.1155/2021/5233462. eCollection 2021.
7
Extract Attenuates Interleukin-1β-Induced Oxidative Stress and Inflammatory Response in Chondrocytes by Suppressing the Activation of NF-κB, p38 MAPK, and PI3K/Akt.提取物通过抑制 NF-κB、p38 MAPK 和 PI3K/Akt 的激活来减轻软骨细胞中白细胞介素-1β诱导的氧化应激和炎症反应。
Int J Mol Sci. 2018 Aug 7;19(8):2308. doi: 10.3390/ijms19082308.
8
Schisandrae Fructus Inhibits IL-1β-Induced Matrix Metalloproteinases and Inflammatory Mediators Production in SW1353 Human Chondrocytes by Suppressing NF-κB and MAPK Activation.五味子果实通过抑制NF-κB和MAPK激活来抑制白细胞介素-1β诱导的人SW1353软骨细胞中基质金属蛋白酶和炎症介质的产生。
Drug Dev Res. 2015 Dec;76(8):474-83. doi: 10.1002/ddr.21283. Epub 2015 Oct 7.
9
Paeonol Inhibits IL-1β-Induced Inflammation via PI3K/Akt/NF-κB Pathways: In Vivo and Vitro Studies.丹皮酚通过 PI3K/Akt/NF-κB 通路抑制 IL-1β诱导的炎症:体内和体外研究。
Inflammation. 2017 Oct;40(5):1698-1706. doi: 10.1007/s10753-017-0611-8.
10
Blocking of the P2X7 receptor inhibits the activation of the MMP-13 and NF-κB pathways in the cartilage tissue of rats with osteoarthritis.阻断P2X7受体可抑制骨关节炎大鼠软骨组织中MMP-13和NF-κB信号通路的激活。
Int J Mol Med. 2016 Dec;38(6):1922-1932. doi: 10.3892/ijmm.2016.2770. Epub 2016 Oct 13.

引用本文的文献

1
The effect of IGF-1 on cartilage injury in bone marrow mesenchymal stem cells through the BMP2-Smad1/5 signaling pathway.胰岛素样生长因子-1通过骨形态发生蛋白2- Smad1/5信号通路对骨髓间充质干细胞软骨损伤的影响。
In Vitro Cell Dev Biol Anim. 2025 Mar;61(3):340-356. doi: 10.1007/s11626-025-01015-4. Epub 2025 Mar 5.
2
Attenuation of PI3K/AKT signaling pathway by leaf flavonoid-rich extracts in streptozotocin-induced diabetic male rats.富含叶黄酮提取物对链脲佐菌素诱导的糖尿病雄性大鼠PI3K/AKT信号通路的抑制作用
Biochem Biophys Rep. 2024 May 16;38:101735. doi: 10.1016/j.bbrep.2024.101735. eCollection 2024 Jul.
3
Total Flavonoids of Rhizoma Drynariae Treat Osteoarthritis by Inhibiting Arachidonic Acid Metabolites Through AMPK/NFκB Pathway.

本文引用的文献

1
Influence of obesity on remodeling of lung tissue and organization of extracellular matrix after blunt thorax trauma.肥胖对钝性胸部创伤后肺组织重塑和细胞外基质组织的影响。
Respir Res. 2020 Sep 17;21(1):238. doi: 10.1186/s12931-020-01502-0.
2
Tumor suppressor LHPP regulates the proliferation of colorectal cancer cells via the PI3K/AKT pathway.抑癌基因 LHPP 通过 PI3K/AKT 通路调控结直肠癌细胞的增殖。
Oncol Rep. 2020 Feb;43(2):536-548. doi: 10.3892/or.2019.7442. Epub 2019 Dec 20.
3
Identifying the role of ASPN and COMP genes in knee osteoarthritis development.
骨碎补总黄酮通过AMPK/NFκB途径抑制花生四烯酸代谢产物治疗骨关节炎
J Inflamm Res. 2023 Sep 20;16:4123-4140. doi: 10.2147/JIR.S418345. eCollection 2023.
4
N6-methyladenosine (m6A) methyltransferase WTAP-mediated miR-92b-5p accelerates osteoarthritis progression.N6-甲基腺嘌呤(m6A)甲基转移酶 WTAP 介导的 miR-92b-5p 促进骨关节炎进展。
Cell Commun Signal. 2023 Aug 10;21(1):199. doi: 10.1186/s12964-023-01228-8.
5
Gut microbiome dysregulation drives bone damage in broiler tibial dyschondroplasia by disrupting glucose homeostasis.肠道微生物组失调通过破坏葡萄糖内环境稳态导致肉鸡胫骨软骨发育不良的骨损伤。
NPJ Biofilms Microbiomes. 2023 Jan 3;9(1):1. doi: 10.1038/s41522-022-00360-6.
6
A Study on the Potential Mechanism of Shujin Dingtong Recipe against Osteoarthritis Based on Network Pharmacology and Molecular Docking.基于网络药理学和分子对接的术骏定痛方治疗骨关节炎作用机制的研究。
Comput Math Methods Med. 2022 Nov 26;2022:1873004. doi: 10.1155/2022/1873004. eCollection 2022.
7
Network and Experimental Pharmacology to Decode the Action of Wendan Decoction Against Generalized Anxiety Disorder.网络与实验药理学解析温胆汤治疗广泛性焦虑障碍的作用。
Drug Des Devel Ther. 2022 Sep 27;16:3297-3314. doi: 10.2147/DDDT.S367871. eCollection 2022.
8
Chondroprotective Effects of Gubitong Recipe via Inhibiting Excessive Mitophagy of Chondrocytes.骨痹通方通过抑制软骨细胞过度线粒体自噬发挥软骨保护作用。
Evid Based Complement Alternat Med. 2022 Aug 1;2022:8922021. doi: 10.1155/2022/8922021. eCollection 2022.
9
Research on Herbal Therapies for Osteoarthritis in 2004-2022: A Web of Science-Based Cross-Sectional Bibliometric Analysis.2004 - 2022年骨关节炎草药疗法的研究:基于科学网的横断面文献计量分析
Evid Based Complement Alternat Med. 2022 Jul 30;2022:6522690. doi: 10.1155/2022/6522690. eCollection 2022.
10
Network Pharmacology-Based Strategy to Investigate the Mechanisms of in Treating Osteoarthritis.基于网络药理学的方法探究[具体药物]治疗骨关节炎的机制 。(你原文中“in Treating Osteoarthritis”前应该有具体药物名称未给出完整)
Evid Based Complement Alternat Med. 2022 Jul 14;2022:1826299. doi: 10.1155/2022/1826299. eCollection 2022.
鉴定 ASPN 和 COMP 基因在膝骨关节炎发展中的作用。
J Orthop Surg Res. 2019 Oct 29;14(1):337. doi: 10.1186/s13018-019-1391-7.
4
The role of matrix metalloproteinases in osteoarthritis pathogenesis: An updated review.基质金属蛋白酶在骨关节炎发病机制中的作用:最新综述。
Life Sci. 2019 Oct 1;234:116786. doi: 10.1016/j.lfs.2019.116786. Epub 2019 Aug 22.
5
Inflammatory cytokines via up-regulation of aquaporins deteriorated the pathogenesis of early osteoarthritis.炎症细胞因子通过上调水通道蛋白恶化了早期骨关节炎的发病机制。
PLoS One. 2019 Aug 12;14(8):e0220846. doi: 10.1371/journal.pone.0220846. eCollection 2019.
6
Emerging Trend in the Pharmacotherapy of Osteoarthritis.骨关节炎药物治疗的新趋势
Front Endocrinol (Lausanne). 2019 Jul 2;10:431. doi: 10.3389/fendo.2019.00431. eCollection 2019.
7
OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis.OARSI 骨关节炎治疗指南:膝关节、髋关节和多关节骨关节炎的非手术治疗。
Osteoarthritis Cartilage. 2019 Nov;27(11):1578-1589. doi: 10.1016/j.joca.2019.06.011. Epub 2019 Jul 3.
8
Osteoarthritis.骨关节炎。
Lancet. 2019 Apr 27;393(10182):1745-1759. doi: 10.1016/S0140-6736(19)30417-9.
9
Resveratrol inhibits IL-1β-mediated nucleus pulposus cell apoptosis through regulating the PI3K/Akt pathway.白藜芦醇通过调节 PI3K/Akt 通路抑制 IL-1β 介导的髓核细胞凋亡。
Biosci Rep. 2019 Mar 26;39(3). doi: 10.1042/BSR20190043. Print 2019 Mar 29.
10
Expression of Matrix Metalloproteinases, Tissue Inhibitors of Metalloproteinases, and Interleukins in Vertebral Cartilage Endplate.基质金属蛋白酶、金属蛋白酶组织抑制剂和白细胞介素在椎体软骨终板中的表达
Orthop Surg. 2018 Nov;10(4):306-311. doi: 10.1111/os.12409. Epub 2018 Nov 25.